Gene: MISP3
Official Full Name: MISP family member 3provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30862 | MISP3 Knockout cell line (HeLa) | Human | MISP3 | 1:3~1:6 | Negative | Online Inquiry |
KO30863 | MISP3 Knockout cell line (HCT 116) | Human | MISP3 | 1:2~1:4 | Negative | Online Inquiry |
KO30864 | MISP3 Knockout cell line (HEK293) | Human | MISP3 | 1:3~1:6 | Negative | Online Inquiry |
KO30865 | MISP3 Knockout cell line (A549) | Human | MISP3 | 1:3~1:4 | Negative | Online Inquiry |
MISP3 Gene Knockout Cell Lines are genetically modified cell lines that utilize CRISPR-Cas9 technology to specifically disrupt the MISP3 gene function. MISP3, which is implicated in various cellular processes including tumorigenesis and cellular differentiation, plays a pivotal role in cancer biology and cellular signaling pathways. These knockout cell lines enable researchers to systematically investigate the biological implications of MISP3 loss, facilitating a better understanding of its role in health and disease.
The key functionality of MISP3 Gene Knockout Cell Lines lies in their ability to provide a stable, controlled environment in which the effects of MISP3 disruption on cellular behavior can be observed. By employing precision genome editing, these cell lines allow for the study of downstream signaling pathways and gene regulation that are influenced by the absence of MISP3, making them invaluable tools for elucidating the role of this gene in molecular and cellular contexts.
In scientific research and clinical applications, these knockout cell lines are crucial for developing therapeutic strategies and drug screening methods targeting malignancies where MISP3 plays a significant role. This product's use extends beyond fundamental research; it has potential applications in translational medicine, particularly in identifying biomarkers for cancer therapies.
Compared to traditional gene knockout techniques, MISP3 Gene Knockout Cell Lines offer enhanced specificity and efficiency. The CRISPR-Cas9 method reduces off-target effects, providing high fidelity in gene disruption. Additionally, these cell lines have undergone rigorous validation to ensure consistent performance across experiments, setting them apart from conventional products that may yield varying results.
For researchers and clinicians focused on cancer biology and genetic regulation, MISP3 Gene Knockout Cell Lines represent an indispensable asset, aiding in the discovery of new insights and advancements in treatment modalities. Our company is dedicated to providing high-quality biological products, drawing from extensive scientific expertise and innovation to support the needs of the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.